An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Shapiro, MD
Barrow Neurological Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Queen Elizabeth Ii Health Sciences Center
Halifax, Nova Scotia, Canada
- Caner Centre of Southwestern Ontario/ Kingston General Hospital
Kingston, Ontario, Canada
- Ottawa Regional Cancer Center
Ottawa, Ontario, Canada
- Sunnybrook and Women'S College Health Sciences Center
Toronto, Ontario, Canada
- Barrow Neurological Institute
Phoenix, Arizona, United States
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Uc Davis Medical Center, Division of Medical Oncology
Sacramento, California, United States
- Uc San Diego Cancer Center
San Diego, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Colorado Neurological Institute Center for Brain & Spinal Tumors
Englewood, Colorado, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Cancer Institute of Orlando
Orlando, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- Feinberg School of Medicine, Northwestern University
Chicago, Illinois, United States
- Evanston Northwestern Healthcare
Evanston, Illinois, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Hermelin Brain Tumor Center, Henry Ford Hospital
Detroit, Michigan, United States
- Dent Neurologic Institute
Amherst, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Good Samaritan Hospital
Cincinnati, Ohio, United States
- University Hematology Oncology Care, Llc
Cincinnati, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Oregon Clinic
Portland, Oregon, United States
- Virginia Mason Clinic
Seattle, Washington, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2005
- Primary completion
- 31 Mar 2009
- Completion
- 30 Apr 2009
- Last update posted
- 31 Aug 2012
- Registered enrollment
- 112
- Registry id
- NCT00226655
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.